On Nov. 17, 2023, the Oregon Department of Agriculture reported that the United States Department of Agriculture’s National…
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Nov. 10, 2023, the Centers for Disease Control and Prevention (CDC) estimated that from October 1, 2023,…
On Nov. 9, 2023, the U.S. Food and Drug Administration (FDA) approved Valneva’s Ixchiq, the first chikungunya vaccine….
On Oct. 31, 2023, Novavax announced that the European Commission had granted approval for Nuvaxovid XBB.1.5 dispersion for…
On Oct. 25, 2023, Bavarian Nordic announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory…
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) had granted full approval for Novavax’s…
On Oct. 12, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that two fatal human…
On Oct. 11, 2023, the European Commission, the European Investment Bank and the Bill & Melinda Gates Foundation…
On Oct. 9, 2023, GlaxoSmithKline announced that it had reached an exclusive agreement with Chongqing Zhifei Biological Products…
On Oct. 3, 2023, Vir Biotechnology announced that the Biomedical Advanced Research and Development Authority (BARDA), part of…
On Oct. 3, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
On Oct. 3, 2023, Novavax announced that it’s COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) had received Emergency Use…
On Oct. 2, 2023, France began vaccinating ducks against bird flu to try and stem the virus that…
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
On Oct. 2, 2023, the World Health Organization (WHO) announced it had recommended a new vaccine, R21/Matrix-M, developed…
On Sept. 29, 2023, The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) announced it…
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…
On Sept. 25, 2023, the Washington State Department of Health confirmed the presence of West Nile virus in…
On Sept. 20, 2023, the National Institutes of Health announced that a trial of a preventive HIV vaccine…
On Sept. 15, 2023, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) announced they had…
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…